Akums Drugs Reports 12% EBITDA and 15% PAT Growth in Q3 FY25
New Delhi, February 7, 2025: Akums Drugs and Pharmaceuticals Ltd., has announced its consolidated financial results for the quarter ended December 31, 2024, delivering 12% increase in Adjusted EBITDA on year on year basis. Key Highlights: Quarter ended December 31, 2024 9 months ended December 31, 2024 • Adj EBITDA Margin at […]